• Explore /
  • Poster
  • / The preliminary efficacy and safety data of KN046 in patients failed on prior immune checkpoint inhibitors therapy.

The preliminary efficacy and safety data of KN046 in patients failed on prior immune checkpoint inhibitors therapy.

Abstract Video & Slides Poster

Authors

null

Hongyun Zhao

Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, China

Hongyun Zhao , Yuxiang Ma , Yang Zhang , Shaodong Hong , Yunpeng Yang , Wenfeng Fang , June Xu , Hardy Van , Paul Kong , Fei Yang , Jingying Li , Yao Lu , Li Zhang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Discussion Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Immune Checkpoint Inhibitors

Clinical Trial Registration Number

NCT03529526

Citation

J Clin Oncol 38: 2020 (suppl; abstr 3020)

DOI

10.1200/JCO.2020.38.15_suppl.3020

Abstract #

3020

Poster Bd #

84

Abstract Disclosures

Similar Posters

First Author: Gang Jin

First Author: Robert J. Motzer

First Author: Jermaine Coward

First Author: Brendan D. Curti